ODDB.org: Open Drug Database

Spirig HealthCare AG - Sitagliptin Metformin XR Spirig HC 100/1000 mg, Tabletten mit veränderter Wirkstofffreisetzung

Swissmedic Registration	69160	Sequence	03
Product name	Sitagliptin Metformin XR Spirig HC 100/1000 mg	Description	Tabletten mit veränderter Wirkstofffreisetzung
ATC-Classification	A10BD07	ATC-Description	Metformin and Sitagliptin
Introduction of Sequence	03.08.2023

Composition

metformini hydrochloridum 1000 mg, sitagliptinum 100 mg ut sitagliptini hydrochloridum monohydricum, hypromellosum, magnesii stearas, calcii hydrogenophosphas, cellulosum microcristallinum, natrii stearylis fumaras, carmellosum natricum conexum, Überzug: poly(alcohol vinylicus), E 171, macrogolum 4000, talcum, E 172 (flavum), E 172 (rubrum), pro compresso, natrium 1.4 mg.

Packungsbestandteile

Galenic Form

Tablets

Active Agent	Dose
Metformin Hydrochloride	1000 mg
Sitagliptine	100 mg

BAG: Active Agent	Dose
Metformin Hydrochloride	1000 mg
Sitagliptine	100 mg

Inactive agents	Dose	additional_information
(Flavum)
(Rubrum)
Calcium Hydrogen Phosphate
Carmellosum Natricum Conexum
Cellulosum Microcristallinum
E 171		color.
E 172		color.
Hypromellosum
Macrogol	4000
Magnesii Stearas
Natrii Stearylis Fumaras
Sodium	1.4 mg
Poly(Alcohol Vinylicus)		Überzug
Pro Compresso
Talcum

Package number	Package Size	EFP	CP	Category	SL	Out of trade (MedRef)
005	30	15.35	33.10	B	SL	No
006	90	45.35	65.75	B	SL	No

2025	©ywesee GmbH